LMAN2 Antikörper (C-Term)
Kurzübersicht für LMAN2 Antikörper (C-Term) (ABIN953193)
Target
Alle LMAN2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 284-314, C-Term
-
Spezifität
- This antibody recognizes Human LMAN2 (C-term).
-
Aufreinigung
- Protein A column, followed by peptide affinity purification
-
Immunogen
- KLH conjugated synthetic peptide between 284-314 amino acids from the C-terminal region of Human LMAN2
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- LMAN2 (Lectin, Mannose-Binding 2 (LMAN2))
-
Andere Bezeichnung
- LMAN2
-
Hintergrund
- LMAN2 is a type I transmembrane lectin that shuttles between the endoplasmic reticulum, the Golgi apparatus and the plasma membrane. The encoded protein binds high mannose type glycoproteins and may facilitate their sorting, trafficking and quality control.Synonyms: C5orf8, Glycoprotein GP36b, LMAN2, Lectin mannose-binding 2, Vesicular integral-membrane protein VIP36
-
Molekulargewicht
- 40229 Da
-
Gen-ID
- 10960
-
NCBI Accession
- NP_006807
-
Pathways
- SARS-CoV-2 Protein Interaktom
Target
-